Front page
Nothing from your lists
What covered companies filed with the SEC, day by day.
Nothing from your lists
+ 7 more
Nothing from your lists
Cumulus Media Inc · “On the Effective Date, in accordance with the Plan, the Company issued $50 million in aggregate principal amount of 10%/8% Senior Secured PIK Toggle Notes due 2031 (the “Convertible Notes”) to holders of Allowed 2029 Secured Claims.”¶1
XTI Aerospace, Inc. · “XTI Drones Holdings did not make the required payments under the DN Note and the AR Note.”¶1
GoPro, Inc. · “The Company plans to restate the 2025 Audited Financial Statements and include them in an amendment to the 2025 10-K (the “2025 10-K/A”).”¶1
Nothing from your lists
Nothing from your lists
Nothing from your lists
Nothing from your lists
Cumulus Media Inc. emerged from Chapter 11 on October 16, 2026, when the Plan became effective and the Company Parties exited the Chapter 11 Cases.¶2¶3
Pre-emergence Class A and Class B common stock was canceled, and 352,025 shares of New Class A Common Stock and 285,975 shares of New Class B Common Stock were issued, representing 100% of outstanding equity.¶3¶4
The Company entered a four-year ABL Credit Agreement providing up to $100.0 million, and issued $50 million of Convertible Notes due 2031 to holders of Allowed 2029 Secured Claims.¶5¶1
Directors Andrew W. Hobson, Elizabeth Abrams, Deborah A. Farrington, Carol Flaton, Steven M. Galbraith and David M. Tolley ceased serving, and Heath B. Freeman, Philip A. Hudson, Greg Stuecheli and Scott Manson joined the board.¶6
Former holders of the Company's common stock will not receive any recovery or distribution on account of their interests under the Plan, which have no value.¶7¶8
XTI Drones Holdings did not make the required payments of $1,380,000 under the DN Note and $120,000 under the AR Note due on or before September 30, 2026.¶1
An event of default occurred under the DN Note and the AR Note on October 11, 2026, after a ten-day grace period ended at the end of October 10, 2026.¶1
Interest on the DN Note and the AR Note accrues at a default rate of 9.25% per annum, and the DN Seller and AR Seller may declare the unpaid principal immediately due and payable.¶2¶3
The Credit Agreement Defaults mean the Lender is not obligated to make loans, and approximately $8.4 million of revolving loans were outstanding under the Credit Agreement as of October 16, 2026.¶4
The Company does not currently have sufficient available liquidity to repay all amounts that would be due if the DN Note and the AR Note or the Credit Agreement obligations were accelerated.¶5
High Roller Technologies concluded its unaudited financial statements for the periods ended March 31, 2026 and June 30, 2026 should no longer be relied upon and must be restated.¶1
The error relates to accounting for warrants issued to the placement agent for the January 2026 registered direct offering, with approximately $1.0 million of grant-date fair value recorded as general and administrative expense.¶1
Correcting the error reduces the net loss by approximately $1.0 million, from $3.0 million to $2.0 million for the three months ended March 31, 2026, and from $5.3 million to $4.3 million for the six months ended June 30, 2026.¶2
The error is non-cash and does not affect revenue, cash and cash equivalents, working capital, total stockholders' equity or net cash flows.¶2
On October 9, 2026, the Audit Committee concluded that the 2025 audited, Q3 2025 and 2026 quarterly financial statements were materially misstated due to debt instrument accounting errors and should no longer be relied upon.¶2
The Company plans to restate the 2025 10-K, the Q3 2025 financial statements, and its Q1 and Q2 2026 Form 10-Q filings, as soon as reasonably practicable.¶1
For the year ended December 31, 2025, net loss was $92.6 million as restated, compared with $93.5 million as previously reported.¶3
For the six months ended June 30, 2026, net loss was $127.5 million as restated, compared with $131.8 million as previously reported.¶4
The errors do not affect revenue, gross margin, operating loss, cash, operating cash flows, EBITDA or non-GAAP operating income in any restated period.¶5
On October 15, 2026, the exchange offer was completed, with Medtronic accepting 55,032,401 Medtronic ordinary shares in exchange for 252,813,348 shares of MiniMed common stock.¶2¶1
As a result, Medtronic no longer owns any shares of common stock of MiniMed.¶1
Linnea Burman, Scott Cundy, Laura Mauri, and Matthew R. Walter resigned from the Board of Directors, effective October 15, 2026.¶3
The Board decreased its size from 11 to eight and appointed Amy Bricker as a director effective October 15, 2026, to fill the resulting vacancy.¶4
Amy Bricker is Executive Vice President, Chief Enterprise Pharmacy Officer of Walgreen Co., and the Board has determined she is independent.¶5¶6
As a result of the consummation of the Merger, a change of control of the Company occurred and the Company became a wholly owned subsidiary of Parent.¶1
The total amount of cash consideration payable to the Company's equityholders at closing in connection with the Merger was approximately $1.3 billion.¶1
Parent funded the Merger with approximately $2.9 billion in equity investments by funds affiliated with MIC Capital Management UK LLP (Mubadala), incremental term loans, and cash on hand of the Company.¶1
On October 13, 2026, Espey Mfg. & Electronics Corp. dismissed WithumSmith+Brown, PC as its independent registered public accounting firm, upon Audit Committee recommendation and approval.¶1
The Audit Committee selected PKF O’Connor Davies as the new independent registered public accounting firm for the fiscal year ending June 30, 2027, subject to completion of PKF’s standard client acceptance procedures.¶1
Withum’s reports on the financial statements for the fiscal years ended June 30, 2025 and June 30, 2026 contained no adverse opinion or disclaimer of opinion and were not qualified or modified.¶2
During the fiscal years ended June 30, 2025 and June 30, 2026, the filing reports no disagreements with Withum and no reportable events within the meaning of Item 304 of Regulation S-K.¶3¶4
Withum’s letter to the SEC, dated October 15, 2026, is attached as Exhibit 16.1.¶5
Stephano Slack LLC resigned as Arrive AI Inc.'s independent registered public accounting firm, effective October 13, 2026.¶1
Stephano Slack's audit report for the fiscal year ended December 31, 2025 included an explanatory paragraph regarding substantial doubt about the Company's ability to continue as a going concern.¶2
The Company identified a material weakness in internal control over financial reporting, and on April 15, 2026, it filed amended Quarterly Reports on Form 10-Q/A for the quarters ended June 30, 2025 and September 30, 2025.¶3
On October 13, 2026, the Audit Committee approved and the Company engaged M&K CPAS, PLLC as its independent registered public accounting firm.¶4
On October 9, 2026, the Audit Committee dismissed KPMG Accountants N.V. as Terra Innovatum Global N.V.'s independent registered public accounting firm, effective October 12, 2026.¶1
The change is not the result of any disagreement with KPMG, and the filing reports no reportable events except material weaknesses in internal control over financial reporting that have not been remediated.¶1¶2
The Audit Committee approved the engagement of MaloneBailey, LLP as the new independent registered public accounting firm for the fiscal year ending December 31, 2026, subject to client acceptance procedures.¶3
On October 14, 2026, PharmaCyte Biotech's Audit Committee dismissed CBIZ CPAs P.C. as the company's independent registered public accounting firm, effective that date.¶1
On October 14, 2026, the Audit Committee approved the engagement of Grassi & Co., CPAs, P.C. as the new independent registered public accounting firm for the fiscal year ending April 30, 2027.¶2
CBIZ CPAs' reports on the company's financial statements for fiscal years ended April 30, 2026 and April 30, 2025 contained no adverse opinion or disclaimer of opinion and were not qualified or modified.¶3
The filing discloses material weaknesses in internal control over financial reporting relating to insufficient segregation of duties of the Chief Financial Officer and insufficient management review controls.¶4
On October 15, 2026, Asure Software entered into a Credit Agreement with MUFG Bank as administrative agent, allowing borrowings up to $115 million, with $85.0 million drawn at closing.¶2¶3
The Company terminated its MC Credit Agreement with MidCap and paid an aggregate of approximately $62.6 million as the Payoff Amount, including $2.4 million in prepayment and termination fees.¶4
On October 15, 2026, the Company acquired assets of a southeastern U.S. payroll processing business for $26.5 million, including $13.5 million in cash, a $3.0 million promissory note, and 1,206,141 shares of Common Stock.¶1¶5
On October 9, 2026, CID HoldCo entered into Settlement Agreements with CEO Edmund S. Nabrotzky, CFO and COO Charles Maddox, and CTO Vijayan Nambiar to cancel executive loans totaling $368,107.25 in principal and interest.¶2¶1¶3¶4
The Company agreed to pay approximately $37,075 in aggregate and issue 55,613 Settlement Shares at a deemed price of $6.00 per share, and received no cash proceeds from the share issuance.¶5¶6
The waiver and release becomes effective once the Settlement Shares are issued and the Cash Portion is paid, which the Company expects to do on or before December 31, 2026.¶7¶8
As of October 15, 2026, the Company committed to issue 752,889 Creditor Shares at a deemed price of approximately $6.00 per share to other creditors in exchange for waiver of indebtedness.¶9¶10
On October 13, 2026, Elk Creek Resources Corp. entered into an Offtake Agreement with Traxys North America LLC covering ferroniobium and other products from the Elk Creek Project in southeast Nebraska.¶1
The Offtake Agreement supersedes and replaces the prior ferroniobium and scandium offtake agreements between the Company and Traxys, including the ferroniobium offtake agreement originally entered into on June 13, 2016.¶1
Traxys will purchase, on a take-or-pay basis, 50% of the Elk Creek Project's annual ferroniobium production or, at Traxys’ election, 3,700 metric tonnes of ferroniobium per year.¶2
Traxys will have the exclusive right to market and sell 100% of the Elk Creek Project’s products other than ferroniobium, subject to the terms of the Offtake Agreement.¶2
The Offtake Agreement has a term of 15 years measured from the Commercial Production Date, followed by two automatic one-year renewals unless either party gives notice of non-renewal.¶3
Either party may terminate the Offtake Agreement if, by December 31, 2027, the Export-Import Bank of the United States has not provided final approval of senior debt financing or financial close has not occurred.¶4
Enova International and Grasshopper Bancorp had a December 10, 2025 Agreement and Plan of Merger, amended December 18, 2025, under which Grasshopper would merge into Enova.¶2
On October 16, 2026, Enova and Grasshopper entered into a Mutual Termination Agreement and Release to terminate the Merger Agreement effective that date.¶1
Enova made a $4,000,000 cash payment to Grasshopper under the Termination Agreement, and neither party will pay other fees or have other liabilities related to the Merger Agreement.¶1
On October 15, 2026, Amaze Holdings entered into a Purchase Agreement with C/M Capital Master Fund, LP under which the Company may sell up to $100 million of newly issued common stock to the Purchaser.¶1
The Term runs 36 months from the Commencement Date, and the Company may terminate the Purchase Agreement at any time after that date on one business day's notice at no cost or penalty.¶2¶3
As a commitment fee equal to 2% of the Commitment Amount, or $2,000,000, the Company agreed to issue 1,000,000 shares of Series F Convertible Preferred Stock to the Purchaser.¶4
On October 12, 2026, the Company filed a Certificate of Designation for Series X Preferred Stock with the Nevada Secretary of State, which votes only on specified capitalization amendments with 51% of voting power.¶5¶6
Medicus Pharma Ltd. effected a 1-for-50 share consolidation of its common shares by filing Articles of Amendment with the Ontario Ministry of Public and Business Service Delivery on October 12, 2026.¶1
The Share Consolidation and Articles of Amendment became effective on October 12, 2026, and the Common Shares began trading on a post-Share Consolidation basis on The Nasdaq Capital Market that day.¶1
The shareholders approved the Share Consolidation at the June 3, 2026 Annual General and Special Meeting for up to a maximum ratio of 1-for-50, and the Board unanimously approved the 1-for-50 ratio on September 24, 2026.¶2
Every 50 issued and outstanding Common Shares were automatically consolidated into one new Common Share, and the consolidation did not modify any rights or preferences of the Common Shares.¶3
No fractional shares were issued; fractional shares were rounded down to the nearest whole Common Share and cash was paid in lieu for such fractional shares.¶4
Brady Corporation completed its acquisition of Honeywell's Productivity Solutions and Services business effective August 3, 2026, for a base purchase price of $1.4 billion in cash, subject to customary post-closing adjustments.¶1¶2
The consideration paid at Closing was funded with cash on hand and debt financing, including a $500.0 million term loan, approximately $304.7 million under the new revolving credit facility, and $800.0 million of Senior Notes.¶3¶4
Copart completed its acquisition of ACV Auctions Inc. on October 16, 2026, through a tender offer followed by a merger, with ACV continuing as a wholly owned subsidiary of Parent.¶1¶2
The tender offer at $10.50 per share in cash expired at 5:00 p.m. Eastern Time on October 15, 2026, with 116,818,409 shares validly tendered, representing approximately 68.43% of ACV stock outstanding.¶3¶4
Shares not tendered were converted into the right to receive the same $10.50 per share in cash in the merger, and ACV shares have ceased trading on the New York Stock Exchange.¶2¶5¶6
Vested ACV stock options were cashed out at the Offer Price less exercise price, while unvested options and other restricted stock units were converted into awards on Parent common stock.¶7¶8¶9
The transfer of the Participatory Interests to the Company became effective upon registration, which has been completed, and the Company's name is being updated to TEG Overseas, Inc. in the Uzbekistan registry.¶1
As of October 14, 2026, Temur Zokirov, Bahtiyor Kadirov and Elina Davidyan resigned from the Board, and Anita Mendiratta, Wesley T. Davis, Marc William Kasher, Richard Nolan Sharko and Irodakhon Abduvakhitova commenced serving as Board members, with Ms. Mendiratta as Chair.¶2
The Board established an Audit Committee chaired by Mr. Sharko, a Compensation Committee chaired by Mr. Kasher, and a Nominating and Corporate Governance Committee chaired by Mr. Kasher.¶3
On October 14, 2026, the Board approved a change in the Company's fiscal year end from September 30 to December 31.¶4
On October 12, 2026, Aibotics entered into an Asset Sale and Purchase Agreement with PlayJamaica Limited, and on October 14, 2026 completed the acquisition of the NovaCore Labs assets by issuing 22,500 shares of Series B Preferred Stock with a stated value of $225,000.¶2¶3¶1
PlayJamaica may earn up to an additional $3,000,000 in Series B Preferred Stock if the acquired business generates up to $5,000,000 in cumulative gross revenue during the four years after closing.¶3¶4
